Home
>
ipos-overview
Proposed Symbol | DAVI |
---|---|
Company Name | DAVION HEALTHCARE PLC |
Exchange | |
Share Price | $ |
Employees | 0 (as of 06/01/2025) |
Status | |
Shares Offered | |
Offer amount | $250,000,000.00 |
Shares Over Alloted | |
Company Address | THE CUBE BUILDING MONAHAN ROAD CORK T12 H1XY |
Company Phone | 357 25040052 |
Company Website | www.davionhealthcare.com |
CEO | Jack Kaye |
State of Inc | |
Fiscal Year End | 12-31 |
Total Offering Expense | $871,900.00 |
Shareholder Shares Offered | |
Shares Outstanding | 20,522,500 |
Lockup Period (days) | 180 |
Lockup Expiration | |
Quiet Period Expiration | |
CIK | 0002039072 |
DealId | 1344257-114782 |
Davion Healthcare Plc is an Irish Public Limited Company focused exclusively on the development and commercialization of non-invasive home diagnostic tests for the early detection of health anomalies, including cancers. Our products are classified as Class I medical devices and are fully registered with regulatory authorities in the United States (FDA), the European Union (CE mark), and the United Kingdom (UKCA). Our flagship product, BreastCheck, is a non-invasive home test designed to detect temperature anomalies in breast tissue, which may be indicative of cancer or other health conditions. Our broader pipeline includes a suite of non-invasive home testing kits targeting additional health indicators for early detection, prevention, and wellness monitoring. --- The address and telephone number of our principal executive offices: The Cube Building, Monahan Road. Cork, T12 H1XY, Ireland. Our telephone number: +353 2129330. Our main website is www.davionhealthcare.com. Our agent for service of process in the United States is the Law Offices of David E Price PC, 3 Bethesda Metro Center, Suite 700, Bethesda, MD 20814.